Immune modulation strategies to reduce in-stent restenosis

Yu Mei; Chengyi Dai; Jingjing Shi; Jiayin Fu

doi:10.1039/d5bm00687b

January 1, 2025Biomaterials Science

Immune modulation strategies to reduce in-stent restenosis

View at Publisher

Ask AI

Bookmark

Share

Key Points

Immune modulation strategies significantly reduce in-stent restenosis rates after vascular interventions.
Recent findings suggest immune responses play a crucial role in the development of in-stent restenosis.
Assessment of various immune modulation strategies indicates promising avenues for reducing restenosis risks.
Insights into the interplay of immune responses and vascular injury shed light on potential therapeutic approaches.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Exploration of immune modulation strategies addressing in-stent restenosis, suggesting potential therapeutic advancements.

Abstract

In-stent restenosis (ISR) remains a significant complication following stent implantation, driven by complex interactions between immune responses, vascular injury, and inflammatory cascades.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mei et al. (2025) studied this question.

synapsesocial.com/papers/68c1ad5c54b1d3bfb60e54ec https://doi.org/10.1039/d5bm00687b

View at Publisher

Ask AI

Bookmark

Share

Immune modulation strategies to reduce in-stent restenosis

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Immune modulation strategies to reduce in-stent restenosis

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading